Enterosignatures provide an interpretable and generic model that enables an intuitive characterization of gut microbiome composition

FHS
June 21, 2023
9:54 am

Researchers used a diverse set of 5,230 gut metagenomes to train a study model.

Endo sues Zydus in patent battle over methods of purifying generic version of recalled smoking cessation drug Chantix

Endo International, which lost a patent battle last year over its vasopressin injection Vasostrict, is back in court — this time suing Zydus Pharmaceuticals for

August 11, 2023

Study reveals biological repercussions of UV-C radiation exposure from germicidal lamps

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 16, Issue 9,

May 22, 2024

FTC sues big 3 PBMs for ‘artificially inflated’ insulin prices caused by ‘perverse’ rebating

The U.S. Federal Trade Commission filed a lawsuit against the largest pharmacy benefit managers and their group purchasing organizations for allegedly anticompetitive practices that “artificially

September 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.